ARWR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Arrowhead Pharmaceuticals Inc (ARWR).


$2.41B Market Cap.

As of 11/26/2024 5:00 PM ET (MRY) • Disclaimer

ARWR Market Cap. (MRY)


ARWR Shares Outstanding (MRY)


ARWR Assets (MRY)


Total Assets

$1.14B

Total Liabilities

$948.74M

Total Investments

$578.28M

ARWR Income (MRY)


Revenue

$3.55M

Net Income

-$599.49M

Operating Expense

$604.63M

ARWR Cash Flow (MRY)


CF Operations

-$462.85M

CF Investing

-$420.07M

CF Financing

$870.52M

ARWR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ARWR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,139,802,000 (48.89%)

$765,552,000 (10.64%)

$691,939,000 (-2.56%)

$710,148,000 (35.91%)

Assets Current

$695,471,000 (65.78%)

$419,521,000 (3.51%)

$405,299,000 (5.38%)

$384,597,000 (19.30%)

Assets Non-Current

$444,331,000 (28.41%)

$346,031,000 (20.72%)

$286,640,000 (-11.95%)

$325,551,000 (62.67%)

Goodwill & Intangible Assets

$8,562,000 (-16.57%)

$10,262,000 (-14.21%)

$11,962,000 (-12.45%)

$13,663,000 (-11.07%)

Shareholders Equity

$185,444,000 (-31.66%)

$271,343,000 (-31.91%)

$398,520,000 (-2.52%)

$408,822,000 (-11.47%)

Property Plant & Equipment Net

$431,287,000 (28.53%)

$335,559,000 (99.04%)

$168,588,000 (155.36%)

$66,021,000 (40.42%)

Cash & Equivalents

$102,685,000 (-7.40%)

$110,891,000 (2.67%)

$108,005,000 (-41.44%)

$184,434,000 (28.45%)

Accumulated Other Comprehensive Income

$4,750,000 (247.42%)

-$3,222,000 (-2269.12%)

-$136,000 (-97.10%)

-$69,000 (-483.33%)

Deferred Revenue

$0 (0%)

$866,000 (-99.33%)

$130,049,000 (-46.38%)

$242,550,000 (1157.32%)

Total Investments

$578,276,000 (97.54%)

$292,735,000 (-21.78%)

$374,263,000 (-12.75%)

$428,950,000 (38.64%)

Investments Current

$578,276,000 (97.54%)

$292,735,000 (9.07%)

$268,391,000 (46.38%)

$183,355,000 (6.66%)

Investments Non-Current

$0 (0%)

$0 (0%)

$105,872,000 (-56.89%)

$245,595,000 (78.63%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$1,410,000 (-86.25%)

$10,255,000 (1112.17%)

Trade & Non-Trade Payables

$11,388,000 (-68.25%)

$35,866,000 (1150.56%)

$2,868,000 (-69.67%)

$9,457,000 (38.48%)

Accumulated Retained Earnings (Deficit)

-$1,625,523,000 (-58.43%)

-$1,026,030,000 (-25.01%)

-$820,755,000 (-27.31%)

-$644,692,000 (-27.95%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$510,552,000 (343.30%)

$115,171,000 (41.18%)

$81,576,000 (219.34%)

$25,545,000 (20.85%)

Debt Current

$6,342,000 (-39.96%)

$10,563,000 (280.51%)

$2,776,000 (23.38%)

$2,250,000 (105.48%)

Debt Non-Current

$504,210,000 (382.00%)

$104,608,000 (32.75%)

$78,800,000 (238.27%)

$23,295,000 (16.23%)

Total Liabilities

$948,739,000 (98.32%)

$478,390,000 (74.85%)

$273,600,000 (-9.20%)

$301,326,000 (396.21%)

Liabilities Current

$103,168,000 (-2.17%)

$105,456,000 (-24.05%)

$138,850,000 (-5.25%)

$146,536,000 (260.20%)

Liabilities Non-Current

$845,571,000 (126.73%)

$372,934,000 (176.76%)

$134,750,000 (-12.95%)

$154,790,000 (672.29%)

ARWR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$3,551,000 (-98.52%)

$240,735,000 (-1.03%)

$243,231,000 (75.89%)

$138,287,000 (57.16%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$98,761,000 (6.71%)

$92,549,000 (-25.62%)

$124,431,000 (53.65%)

$80,981,000 (54.91%)

Research & Development Expense

$505,870,000 (43.23%)

$353,188,000 (18.80%)

$297,307,000 (44.08%)

$206,342,000 (60.11%)

Operating Expenses

$604,631,000 (35.65%)

$445,737,000 (5.69%)

$421,738,000 (46.78%)

$287,323,000 (58.61%)

Interest Expense

$32,352,000 (76.54%)

$18,326,000 (0%)

$0 (0%)

-$6,120,000 (33.41%)

Income Tax Expense

-$2,767,000 (-199.39%)

$2,784,000 (-26.45%)

$3,785,000 (189150.00%)

$2,000 (0.00%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$609,693,000 (-191.34%)

-$209,275,000 (-18.57%)

-$176,494,000 (-25.31%)

-$140,848,000 (-66.58%)

Net Income to Non-Controlling Interests

-$10,200,000 (-155.00%)

-$4,000,000 (-828.07%)

-$431,000 (0%)

$0 (0%)

Net Income

-$599,493,000 (-192.04%)

-$205,275,000 (-16.59%)

-$176,063,000 (-25.00%)

-$140,848,000 (-66.58%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$599,493,000 (-192.04%)

-$205,275,000 (-16.59%)

-$176,063,000 (-25.00%)

-$140,848,000 (-66.58%)

Weighted Average Shares

$119,784,000 (12.21%)

$106,750,000 (1.26%)

$105,426,000 (1.62%)

$103,745,000 (3.00%)

Weighted Average Shares Diluted

$119,784,000 (12.21%)

$106,750,000 (1.26%)

$105,426,000 (1.62%)

$103,745,000 (3.00%)

Earning Before Interest & Taxes (EBIT)

-$569,908,000 (-209.46%)

-$184,165,000 (-6.90%)

-$172,278,000 (-17.22%)

-$146,966,000 (-56.78%)

Gross Profit

$3,551,000 (-98.52%)

$240,735,000 (-1.03%)

$243,231,000 (75.89%)

$138,287,000 (57.16%)

Operating Income

-$601,080,000 (-193.21%)

-$205,002,000 (-14.84%)

-$178,507,000 (-19.77%)

-$149,036,000 (-59.98%)

ARWR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$420,072,000 (-336.87%)

-$96,155,000 (-1675.06%)

-$5,417,000 (96.18%)

-$141,678,000 (41.16%)

Net Cash Flow from Financing

$870,520,000 (244.01%)

$253,053,000 (288.20%)

$65,186,000 (476.61%)

$11,305,000 (-95.62%)

Net Cash Flow from Operations

-$462,851,000 (-200.77%)

-$153,890,000 (-13.05%)

-$136,131,000 (-179.46%)

$171,312,000 (278.82%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$12,403,000 (-512.33%)

$3,008,000 (103.94%)

-$76,362,000 (-286.53%)

$40,939,000 (152.06%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$278,603,000 (-445.74%)

$80,582,000 (70.15%)

$47,360,000 (140.10%)

-$118,111,000 (48.38%)

Capital Expenditure

-$141,469,000 (19.96%)

-$176,737,000 (-234.88%)

-$52,777,000 (-123.94%)

-$23,567,000 (-97.18%)

Issuance (Repayment) of Debt Securities

$438,866,000 (75.55%)

$250,000,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$431,654,000 (14038.68%)

$3,053,000 (-41.13%)

$5,186,000 (-54.13%)

$11,305,000 (-95.62%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$4,197,000 (3540.16%)

-$122,000 (-82.09%)

-$67,000 (23.86%)

-$88,000 (-121.46%)

Share Based Compensation

$73,968,000 (-5.33%)

$78,130,000 (-35.37%)

$120,893,000 (57.67%)

$76,673,000 (76.74%)

Depreciation Amortization & Accretion

$18,595,000 (48.84%)

$12,493,000 (19.88%)

$10,421,000 (26.06%)

$8,267,000 (39.13%)

ARWR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-16882.40% (-19691.79%)

-85.30% (-17.82%)

-72.40% (28.95%)

-101.90% (-6.04%)

EBITDA Margin

-15525.60% (-21675.04%)

-71.30% (-7.22%)

-66.50% (33.70%)

-100.30% (-0.50%)

Return on Average Equity (ROAE)

-206.70% (-267.79%)

-56.20% (-33.81%)

-42.00% (-30.03%)

-32.30% (-85.63%)

Return on Average Assets (ROAA)

-66.50% (-170.33%)

-24.60% (2.77%)

-25.30% (-21.05%)

-20.90% (-37.50%)

Return on Sales (ROS)

-16049.20% (-20879.35%)

-76.50% (-8.05%)

-70.80% (33.40%)

-106.30% (0.19%)

Return on Invested Capital (ROIC)

-60.80% (-125.19%)

-27.00% (22.41%)

-34.80% (30.12%)

-49.80% (-25.44%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.87 (72.32%)

-13.99 (29.28%)

-19.79 (56.89%)

-45.9 (10.45%)

Price to Sales Ratio (P/S)

653.4 (5383.83%)

11.91 (-16.82%)

14.32 (-69.41%)

46.84 (-4.98%)

Price to Book Ratio (P/B)

12.98 (22.33%)

10.62 (20.93%)

8.78 (-44.87%)

15.92 (66.90%)

Debt to Equity Ratio (D/E)

5.12 (190.19%)

1.76 (156.62%)

0.69 (-6.78%)

0.74 (458.33%)

Earnings Per Share (EPS)

-5 (-160.42%)

-1.92 (-14.97%)

-1.67 (-22.79%)

-1.36 (-61.90%)

Sales Per Share (SPS)

0.03 (-98.67%)

2.25 (-2.25%)

2.31 (73.07%)

1.33 (52.52%)

Free Cash Flow Per Share (FCFPS)

-5.04 (-62.90%)

-3.1 (-72.82%)

-1.79 (-225.84%)

1.42 (233.08%)

Book Value Per Share (BVPS)

1.55 (-39.10%)

2.54 (-32.75%)

3.78 (-4.09%)

3.94 (-14.05%)

Tangible Assets Book Value Per Share (TABVPS)

9.44 (33.48%)

7.08 (9.69%)

6.45 (-3.92%)

6.71 (33.33%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (75.00%)

-16 (20.00%)

-20 (52.38%)

-42 (6.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-4.46 (73.23%)

-16.65 (21.68%)

-21.25 (52.51%)

-44.75 (6.60%)

Asset Turnover

0 (-98.61%)

0.29 (-17.48%)

0.35 (70.24%)

0.2 (29.75%)

Current Ratio

6.74 (69.46%)

3.98 (36.28%)

2.92 (11.20%)

2.63 (-66.87%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$604,320,000 (-82.78%)

-$330,627,000 (-75.02%)

-$188,908,000 (-227.86%)

$147,745,000 (237.11%)

Enterprise Value (EV)

$2,456,680,857 (-14.03%)

$2,857,673,250 (-16.93%)

$3,439,983,227 (-44.58%)

$6,207,068,352 (47.55%)

Earnings Before Tax (EBT)

-$602,260,000 (-197.43%)

-$202,491,000 (-17.54%)

-$172,278,000 (-22.32%)

-$140,846,000 (-66.58%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$551,313,000 (-221.14%)

-$171,672,000 (-6.06%)

-$161,857,000 (-16.70%)

-$138,699,000 (-57.97%)

Invested Capital

$1,435,939,000 (119.52%)

$654,114,000 (27.09%)

$514,698,000 (31.62%)

$391,060,000 (13.68%)

Working Capital

$592,303,000 (88.59%)

$314,065,000 (17.87%)

$266,449,000 (11.92%)

$238,061,000 (-15.49%)

Tangible Asset Value

$1,131,240,000 (49.78%)

$755,290,000 (11.08%)

$679,977,000 (-2.37%)

$696,485,000 (37.34%)

Market Capitalization

$2,407,986,857 (-16.40%)

$2,880,273,250 (-17.67%)

$3,498,308,227 (-46.25%)

$6,508,905,352 (47.77%)

Average Equity

$290,048,000 (-20.53%)

$364,996,000 (-12.95%)

$419,318,250 (-3.92%)

$436,433,250 (-10.43%)

Average Assets

$901,249,250 (7.80%)

$836,051,250 (20.04%)

$696,458,750 (3.14%)

$675,280,250 (21.29%)

Invested Capital Average

$936,889,000 (37.52%)

$681,287,750 (37.59%)

$495,164,500 (67.67%)

$295,327,750 (25.13%)

Shares

124,315,274 (15.97%)

107,192,901 (1.27%)

105,848,963 (1.52%)

104,259,256 (1.92%)